- Forums
- ASX - By Stock
- ACW
- Ann: ACW XanaCIDD phase 2a trial topline results
Ann: ACW XanaCIDD phase 2a trial topline results, page-40
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
-0.004(12.9%) |
Mkt cap ! $73.21M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 2.7¢ | $938.0K | 33.18M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2741829 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 643372 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 67000 | 0.030 |
4 | 288505 | 0.028 |
13 | 1588683 | 0.027 |
9 | 1359588 | 0.026 |
23 | 4579643 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 1143372 | 3 |
0.029 | 2104523 | 5 |
0.030 | 3821371 | 17 |
0.031 | 2917502 | 6 |
0.032 | 1661622 | 7 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online